3 comments By Eva Kiesler, PhD, Science Writer/Editor   |  Tuesday, October 15, 2013 Memorial Sloan-Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Read this article:
Immune Cells in the Brain Could be Enlisted to Fight Glioblastoma